Literature DB >> 21270112

Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms.

R Reynaud1, F Albarel, A Saveanu, N Kaffel, F Castinetti, P Lecomte, R Brauner, G Simonin, J Gaudart, E Carmona, A Enjalbert, A Barlier, T Brue.   

Abstract

BACKGROUND: Pituitary stalk interruption syndrome (PSIS) is a particular entity in the population of patients with hypopituitarism. Only rare cases have a known genetic cause.
OBJECTIVES: i) To compare subgroups with or without extra-pituitary malformations (EPM) in a cohort of PSIS patients to identify predictive factors of evolution, ii) to determine the incidence of mutations of the known pituitary transcription factor genes in PSIS. Study design We analyzed features of 83 PSIS patients from 80 pedigrees and screened HESX1, LHX4, OTX2, and SOX3 genes.
RESULTS: PSIS had a male predominance and was rarely familial (5%). Pituitary hypoplasia was observed only in the group with EPM. Multiple hormone deficits were observed significantly more often with versus without EPM (87.5 vs 69.5% respectively). Posterior pituitary location along the stalk was a significant protective factor regarding severity of hormonal phenotype. A novel HESX1 causative mutation was found in a consanguineous family, and two LHX4 mutations were present in familial PSIS.
CONCLUSION: PSIS patients with EPM had a more severe hormonal disorder and pituitary imaging status, suggesting an antenatal origin. HESX1 or LHX4 mutations accounted for <5% of cases and were found in consanguineous or familial cases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270112     DOI: 10.1530/EJE-10-0892

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  27 in total

1.  Lhx4 deficiency: increased cyclin-dependent kinase inhibitor expression and pituitary hypoplasia.

Authors:  Peter Gergics; Michelle L Brinkmeier; Sally A Camper
Journal:  Mol Endocrinol       Date:  2015-02-10

2.  Pituitary stalk interruption and olfactory bulbs aplasia/hypoplasia in a man with Kallmann syndrome and reversible gonadotrope and somatotrope deficiencies.

Authors:  Julie Sarfati; Alexandru Saveanu; Jacques Young
Journal:  Endocrine       Date:  2014-11-09       Impact factor: 3.633

3.  Pulsatile GnRH Therapy May Restore Hypothalamus-Pituitary-Testis Axis Function in Patients With Congenital Combined Pituitary Hormone Deficiency: A Prospective, Self-Controlled Trial.

Authors:  Junjie Zheng; Jiangfeng Mao; Hongli Xu; Xi Wang; Bingkun Huang; Zhaoxiang Liu; Mingxuan Cui; Shuyu Xiong; Wanlu Ma; Le Min; Ursula B Kaiser; Min Nie; Xueyan Wu
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

4.  Pituitary stalk interruption syndrome in 59 children: the value of MRI in assessment of pituitary functions.

Authors:  Qian Wang; Yanyan Hu; Guimei Li; Xiaojun Sun
Journal:  Eur J Pediatr       Date:  2013-11-21       Impact factor: 3.183

5.  Molecular analysis of PROP1, POU1F1, LHX3, and HESX1 in Turkish patients with combined pituitary hormone deficiency: a multicenter study.

Authors:  Firdevs Baş; Z Oya Uyguner; Feyza Darendeliler; Zehra Aycan; Ergun Çetinkaya; Merih Berberoğlu; Zeynep Şiklar; Gönül Öcal; Şükran Darcan; Damla Gökşen; Ali Kemal Topaloğlu; Bilgin Yüksel; Mehmet Nuri Özbek; Oya Ercan; Olcay Evliyaoğlu; Semra Çetinkaya; Yaşar Şen; Emre Atabek; Güven Toksoy; Banu Küçükemre Aydin; Rüveyde Bundak
Journal:  Endocrine       Date:  2014-12-11       Impact factor: 3.633

Review 6.  Growth hormone - past, present and future.

Authors:  Michael B Ranke; Jan M Wit
Journal:  Nat Rev Endocrinol       Date:  2018-03-16       Impact factor: 43.330

Review 7.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

Review 8.  Combined pituitary hormone deficiency: current and future status.

Authors:  F Castinetti; R Reynaud; M-H Quentien; N Jullien; E Marquant; C Rochette; J-P Herman; A Saveanu; A Barlier; A Enjalbert; T Brue
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

9.  Identification of HESX1 mutations in Kallmann syndrome.

Authors:  Kayce Newbern; Nithya Natrajan; Hyung-Goo Kim; Lynn P Chorich; Lisa M Halvorson; Richard S Cameron; Lawrence C Layman
Journal:  Fertil Steril       Date:  2013-03-01       Impact factor: 7.329

Review 10.  Insights into non-classic and emerging causes of hypopituitarism.

Authors:  Flavia Prodam; Marina Caputo; Chiara Mele; Paolo Marzullo; Gianluca Aimaretti
Journal:  Nat Rev Endocrinol       Date:  2020-11-27       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.